home / stock / dtc:cc / dtc:cc news

DTC:CC News and Press, Defence Therapeutics Inc. Class A From 03/26/24

Stock Information
Company Name: Defence Therapeutics Inc. Class A
Stock Symbol: DTC:CC
Market: CNQC
Website: defencetherapeutics.com
Menu
DTC:CC DTC:CC Quote DTC:CC Short DTC:CC News DTC:CC Articles DTC:CC Message Board
Get DTC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC:CC - Defence's Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine

Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biotechnology company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce t...
DTC:CC - Defence Completes 2nd Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2 nd tranch...

DTC:CC - Defence Therapeutics Awarded Broad U.S. Patent Covering Its Pioneering Cancer-Killing AccuTOX(R) Technology

Vancouver, British Columbia--(Newsfile Corp. - March 4, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announc...

DTC:CC - Defence Announces Peer-Reviewed Publication on Accum-E7 Anti-Cancer Vaccine in Cancer Science Journal and Financing Update

Vancouver, British Columbia--(Newsfile Corp. - February 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology, is pleased to announce the publication ...
DTC:CC - Defence Therapeutics Completes 1st Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 1 st ...

DTC:CC - Defence Financing

Vancouver, British Columbia--(Newsfile Corp. - January 19, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology announces, further to its news relea...

DTC:CC - Defence Begins Trading on the OTCQB and Arranges Financing

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it arranges ...
DTC:CC - Defence's AccuTOX(R) Impairs Lung Cancer Growth

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it succ...

DTC:CC - RETRANSMISSION: Defence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that the U.S. ...

DTC:CC - Defence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)

Vancouver, British Columbia--(Newsfile Corp. - December 11, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that the U.S. ...
Previous 10 Next 10